Manufacturer profile
CELLTRAZONE CO., LTD.
Ecuador ARCSA·9 registered devices·Nov 24, 2022 – Dec 07, 2022
9
Total devices
1
Risk classes
2022
Earliest
2022
Latest
Recent registrations
Latest 10 ARCSA device registrations
HURO PATH Lysis solution (Contro-reagent)
8c018aead97b3b6c7dca031d31e72a9f
IDec 07, 2022
HURO PATH solution (Non-Gyn)
504ec51159a811f5c721ce2b47b382da
IDec 07, 2022
HURO PATH Lysis solution (Hemolics)
f38c5f85071843aa9b2ac49b648ea256
IDec 07, 2022
HURO PATH solution (Gyn)
00e9f32063a094cf603ce5aeb155c077
IDec 07, 2022
HURO PATH solution (Diluent)
b0f4ab6a24f4890ea2f885e77a7014df
IDec 07, 2022
HURO PATH T
7e611517442be76d914912ecc78699d0
INov 24, 2022
HURO PATH Filter (FNA)
4776e964dc7de038945b3fe9458643fe
INov 24, 2022
HURO PATH Filter
8e7c80dd31fe2162e0ff7ffb3c179c03
INov 24, 2022
HURO PATH S
0b890571846c5570dd2f1309f55af660
INov 24, 2022
Risk class distribution
Devices by risk class
I
9
100.0% of total
About this profile
Explore comprehensive manufacturer profile for CELLTRAZONE CO., LTD. through Pure Global AI's free Ecuador medical device database. This company manufactures 9 medical devices registered with ARCSA across 1 risk class. Their registration history spans from Nov 24, 2022 to Dec 07, 2022.